Результаты поиска - Carmelo Scarpignato

Отмена результатов
  1. 1
    Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam

    Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam по Carmelo Scarpignato

    Опубликовано 2013
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

    Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth по Luigi Gatta, Carmelo Scarpignato

    Опубликовано 2017
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

    Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? по Richard H. Hunt, Carmelo Scarpignato

    Опубликовано 2015
    Полный текст
    Editorial
    Добавить в Избранное
    Сохранить в:
  4. 4
    Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments

    Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments по Carmelo Scarpignato, Richard H. Hunt

    Опубликовано 2024
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation

    Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulph... по Vincenzo Savarino, Fábio Pace, Carmelo Scarpignato

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy

    Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy по Paolo, Caffarra, Carmelo, Scarpignato, Marcello, Maggio

    Опубликовано 2020
    Полный текст Полный текст Полный текст
    Текст
    Добавить в Избранное
    Сохранить в:
  7. 7
    Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

    Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers по Carmelo Scarpignato, Corrado Blandizzi, G.C. Viscomi

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries

    Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries по Sandro Contini, Alim Swarray‐Deen, Carmelo Scarpignato

    Опубликовано 2009
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  9. 9
    Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge

    Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge по Peter J. Whorwell, Robert Lange, Carmelo Scarpignato

    Опубликовано 2024
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy по Luigi Gatta, Nimish Vakil, D. Vaira, Carmelo Scarpignato

    Опубликовано 2013
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  11. 11
    Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

    Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression по Carmelo Scarpignato, Luigi Gatta, Angelo Zullo, Corrado Blandizzi

    Опубликовано 2016
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  12. 12
    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD

    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD по A. P. S. Hungin, Michael Molloy‐Bland, Carmelo Scarpignato

    Опубликовано 2018
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  13. 13
    Determinants of the short‐term gastric damage caused by NSAIDs in man

    Determinants of the short‐term gastric damage caused by NSAIDs in man по Ingvar Bjarnason, Carmelo Scarpignato, Koji Takeuchi, K. D. Rainsford

    Опубликовано 2007
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  14. 14
    Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017

    Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017 по Carmelo Scarpignato, Giovanni Barbara, Ángel Lanas, Lisa L. Strate

    Опубликовано 2018
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  15. 15
    Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks

    Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular r... по Carmelo Scarpignato, Ángel Lanas, Corrado Blandizzi, Willem F. Lems, Matthias Hermann, Richard H. Hunt

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

    Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs по Ingvar Bjarnason, Carmelo Scarpignato, Erik Holmgren, Michael W. Olszewski, K. D. Rainsford, Ángel Lanas

    Опубликовано 2017
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  17. 17
    Reflux related symptoms in patients with normal oesophageal exposure to acid.

    Reflux related symptoms in patients with normal oesophageal exposure to acid. по G.Y. Shi, Stanislas Bruley des Varannes, Carmelo Scarpignato, Marc Le Rhun, J. P. Galmiche

    Опубликовано 1995
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Impact of primary antibiotic resistance on the effectiveness of sequential therapy for <i>Helicobacter pylori</i> infection: lessons from a 5-year study on a large number of strains

    Impact of primary antibiotic resistance on the effectiveness of sequential therapy for <i>Helicobacter pylori</i> infection: lessons from a 5-year study on a large number of strain... по Luigi Gatta, Carmelo Scarpignato, Giulia Fiorini, Jonathan Belsey, Ilaria Maria Saracino, Carlo Ricci, D. Vaira

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Colonic diverticular disease

    Colonic diverticular disease по Antonio Tursi, Carmelo Scarpignato, Lisa L. Strate, Ángel Lanas, Wolfgang Kruis, Adi Lahat, Silvio Danese

    Опубликовано 2020
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  20. 20
    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans

    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans по Carmelo Scarpignato, Werner Dolak, Ángel Lanas, Peter Matzneller, Cecilia Renzulli, Maria Grimaldi, Markus Zeitlinger, Ingvar Bjarnason

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: